Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marrow for Treating Recessive Dystrophic Epidermolysis Bullosa
Clinical trial NCT04153630 · UNKNOWN
Trial details
- NCT number
- NCT04153630
- Sponsor
- Instituto de Investigación Hospital Universitario La Paz
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-17
- Primary completion
- 2021-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.